{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:53:53Z","timestamp":1761893633721},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,10,1]]},"DOI":"10.1093\/ndt\/16.10.2028","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:42:32Z","timestamp":1027723352000},"page":"2028-2033","source":"Crossref","is-referenced-by-count":11,"title":["Elevated levels of plasma von Willebrand factor and the risk of macro\u2010 and microvascular disease in type 2 diabetic patients with microalbuminuria"],"prefix":"10.1093","volume":"16","author":[{"given":"Peter","family":"G\u00e6de","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pernille","family":"Vedel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans\u2010Henrik","family":"Parving","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluf","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,10]]},"reference":[{"key":"key\n\t\t\t\t20180110091317_R1","doi-asserted-by":"crossref","unstructured":"Borch\u2010Johnsen K, Kreiner S. Proteinuria: value as a predictor of cardiovascular mortality in insulin\u2010dependent diabetes mellitus. BMJ1987; 294: 1651\u20131654","DOI":"10.1136\/bmj.294.6588.1651"},{"key":"key\n\t\t\t\t20180110091317_R2","doi-asserted-by":"crossref","unstructured":"Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity\u2010onset diabetes mellitus. N Engl J Med1984; 310: 356\u2013360","DOI":"10.1056\/NEJM198402093100605"},{"key":"key\n\t\t\t\t20180110091317_R3","doi-asserted-by":"crossref","unstructured":"Stehouwer CDA. Von Willebrand factor, dysfunction of the vascular endothelium, and the development of renal and vascular complications in diabetes. In: Mogensen CE, ed. The Kidney and Hypertension in Diabetes Mellitus. 3rd edn. Kluwer, Boston, 1997; 155\u2013163","DOI":"10.1007\/978-1-4757-6749-0_16"},{"key":"key\n\t\t\t\t20180110091317_R4","doi-asserted-by":"crossref","unstructured":"Stehouwer CDA, Nauta JJP, Zeldenrust GC, Hackeng WHL, Donker AJM, Den Ottolander GJH. Urinary albumin excretion, cardiovascular disease and endothelial dysfunction in non\u2010insulin dependent diabetes mellitus. Lancet1992; 340: 319\u2013323","DOI":"10.1016\/0140-6736(92)91401-S"},{"key":"key\n\t\t\t\t20180110091317_R5","doi-asserted-by":"crossref","unstructured":"Fioretto P, Stehouwer CD, Mauer M et al. Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure. Diabetologia1998; 41: 233\u2013236","DOI":"10.1007\/s001250050895"},{"key":"key\n\t\t\t\t20180110091317_R6","doi-asserted-by":"crossref","unstructured":"Stehouwer CD, Yudkin JS, Fioretto P, Nosadini R. How heterogeneous is microalbuminuria in diabetes mellitus? The case for \u2018benign\u2019 and \u2018malignant\u2019 microalbuminuria. Nephrol Dial Transplant1998; 13: 2751\u20132754","DOI":"10.1093\/ndt\/13.11.2751"},{"key":"key\n\t\t\t\t20180110091317_R7","doi-asserted-by":"crossref","unstructured":"G\u00e6de P, Vedel P, Parving H\u2010H, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet1999; 353: 617\u2013622","DOI":"10.1016\/S0140-6736(98)07368-1"},{"key":"key\n\t\t\t\t20180110091317_R8","doi-asserted-by":"crossref","unstructured":"Aldington SJ, Kohner EM, Meuer S, Klein R, Sj\u00f8lie A\u2010K. Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM Complications Study. Diabetologia1995; 38: 437\u2013444","DOI":"10.1007\/BF00410281"},{"key":"key\n\t\t\t\t20180110091317_R9","doi-asserted-by":"crossref","unstructured":"Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S. The electrocardiogram in population studies: a classification system. Circulation1960; 21: 1160\u20131175","DOI":"10.1161\/01.CIR.21.6.1160"},{"key":"key\n\t\t\t\t20180110091317_R10","doi-asserted-by":"crossref","unstructured":"Feldt\u2010Rasmussen B, Dinesen B, Deckert M. Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scan J Clin Lab Invest1985; 45: 539\u2013544","DOI":"10.3109\/00365518509155256"},{"key":"key\n\t\t\t\t20180110091317_R11","doi-asserted-by":"crossref","unstructured":"Ingerslev J. A sensitive ELISA for von Willebrand factor (Vwf:Ag). Scand J Clin Lab Invest1987; 47: 143\u2013149","DOI":"10.3109\/00365518709168882"},{"key":"key\n\t\t\t\t20180110091317_R12","doi-asserted-by":"crossref","unstructured":"Ferri C, Desideri G, Baldoncini R et al. Early activation of vascular endothelium in non\u2010obese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities. Diabetes1998; 47: 660\u2013667","DOI":"10.2337\/diabetes.47.4.660"},{"key":"key\n\t\t\t\t20180110091317_R13","doi-asserted-by":"crossref","unstructured":"Heywood DM, Mansfield MW, Grant PJ. Levels of von Willebrand factor, insulin resistance syndrome and a common vWF gene polymorphism in non\u2010insulin\u2010dependent (type 2) diabetes mellitus. Diab Med1996; 13: 720\u2013725","DOI":"10.1002\/(SICI)1096-9136(199608)13:8<720::AID-DIA176>3.0.CO;2-0"},{"key":"key\n\t\t\t\t20180110091317_R14","doi-asserted-by":"crossref","unstructured":"Fioretto P, Mauer M, Brocco E et al. Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia1996; 39: 1569\u20131576","DOI":"10.1007\/s001250050616"},{"key":"key\n\t\t\t\t20180110091317_R15","doi-asserted-by":"crossref","unstructured":"The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin\u2010converting\u2010enzyme inhibitor, ramipril, on cardiovascular events in high\u2010risk patients. N Engl J Med2000; 342: 145\u2013153","DOI":"10.1056\/NEJM200001203420301"},{"key":"key\n\t\t\t\t20180110091317_R16","doi-asserted-by":"crossref","unstructured":"Jager A, van Hinsberg VWM, Kostense PJ et al. Von Willebrand factor, C\u2010reactive protein and 5\u2010year mortality in diabetic and nondiabetic subjects: the Hoorn Study. Arterioscler Thromb Vasc Biol1999; 19: 3071\u20133078","DOI":"10.1161\/01.ATV.19.12.3071"},{"key":"key\n\t\t\t\t20180110091317_R17","doi-asserted-by":"crossref","unstructured":"Jager A, van Hinsberg VWM, Kostense PJ et al. Prognostic implications of retinopathy and a high plasma von Willebrand factor concentration in type 2 diabetic subjects with microalbuminuria. Nephrol Dial Transplant2001; 16: 529\u2013536","DOI":"10.1093\/ndt\/16.3.529"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/16\/10\/2028\/23369373\/162028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T08:59:59Z","timestamp":1583312399000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/16\/10\/2028\/1866174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10,1]]},"references-count":17,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2001,10]]},"published-print":{"date-parts":[[2001,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/16.10.2028","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2001,10]]},"published":{"date-parts":[[2001,10,1]]}}}